A new policy shift could open the door to clinical use of drugs like psilocybin and MDMA, but legal and safety questions ...
Founders of the Integrative Psychiatry Institute, Dr. Will Van Derveer and Keith Kurlander, discuss their new book, Psychedelic Therapy: A Revolutionary Approach to Restoring Mental Health and ...
To honor that history, Zide Door is marking the 4/20 event with special offerings for members starting April 17 through April 20. To celebrate the four-day period, the church will grant free ...
In 1943, a chemist in Switzerland synthesized a drug that alters consciousness. His discovery changed the study of medicine, ...
The largest brain imaging analysis of psychedelics to date, recently published in Nature Medicine, has identified two ...
Researchers created a new questionnaire to measure major life changes linked to psychedelic use and found that most surveyed ...
Under federal law, cannabis is a Schedule I drug. According to this designation, cannabis has “a high potential for abuse” ...
Researchers from McGill University and Mila, Quebec’s artificial intelligence institute, brought together 89 experts from 17 ...
Drug trials generally involve comparing a treatment with a nonactive, placebo version, an approach called "blinding" because ...
A new study suggests that four psychoactive compounds work in surprisingly similar ways, and that they break down the ...
In addition to the artificially induced LSD state, there are other, naturally occurring temporary states in which there is a collapse of the normal routines by which the mind ordinarily processes the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results